These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 27371849)
1. [Expression and clinical significance of IL-33 in patients with non-small cell lung cancer]. Feng Y; Zhu Y; Luo G; Wang Z; Yu P; Zheng L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):808-11. PubMed ID: 27371849 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer. Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593 [TBL] [Abstract][Full Text] [Related]
4. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome. Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284 [TBL] [Abstract][Full Text] [Related]
5. Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer. Lu C; Wang X; Zhu H; Feng J; Ni S; Huang J Oncotarget; 2015 Sep; 6(28):24912-21. PubMed ID: 26305508 [TBL] [Abstract][Full Text] [Related]
6. Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma. Yang M; Feng Y; Yue C; Xu B; Chen L; Jiang J; Lu B; Zhu Y PLoS One; 2018; 13(3):e0193428. PubMed ID: 29499051 [TBL] [Abstract][Full Text] [Related]
7. The clinical significance of transforming acidic coiled-coil protein 3 expression in non-small cell lung cancer. Jiang F; Kuang B; Que Y; Lin Z; Yuan L; Xiao W; Peng R; Zhang X; Zhang X Oncol Rep; 2016 Jan; 35(1):436-46. PubMed ID: 26531241 [TBL] [Abstract][Full Text] [Related]
8. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis. Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. Yang J; Liu H; Wang H; Sun Y Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213 [TBL] [Abstract][Full Text] [Related]
10. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis. Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS Int J Clin Exp Pathol; 2014; 7(12):8881-6. PubMed ID: 25674259 [TBL] [Abstract][Full Text] [Related]
11. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer. Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287 [TBL] [Abstract][Full Text] [Related]
13. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer]. Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534 [TBL] [Abstract][Full Text] [Related]
14. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma. Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274 [TBL] [Abstract][Full Text] [Related]
15. [Expression of special AT-rich sequence-binding protein mRNA and its clinicopathological significance in non-small cell lung cancer]. Zhou LY; Liu F; Tong J; Chen QQ; Zhang FW Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):534-7. PubMed ID: 19304547 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-153 expression and prognosis in non-small cell lung cancer. Chen WJ; Zhang EN; Zhong ZK; Jiang MZ; Yang XF; Zhou DM; Wang XW Int J Clin Exp Pathol; 2015; 8(7):8671-5. PubMed ID: 26339455 [TBL] [Abstract][Full Text] [Related]
17. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer]. Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277 [TBL] [Abstract][Full Text] [Related]
18. [Expression of endoglin in human non-small cell lung cancer and its clinical significance]. Li M; Lu S; Liu X; Zhao J; Zhang H; Ling C Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):581-4. PubMed ID: 23746240 [TBL] [Abstract][Full Text] [Related]
19. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer. Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672 [TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis. Bonnesen B; Pappot H; Holmstav J; Skov BG Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]